The Antiepileptic Drugs (AED) Market was valued at USD 18.21 billion in 2023 and is projected to reach USD 26.30 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024-2031. Increasing prevalence of epilepsy, advancements in drug formulations, and growing awareness of epilepsy management are major drivers fueling market growth.Market OverviewAntiepileptic drugs are medications designed to prevent seizures in individuals with epilepsy or other...
more